Patent ID: 8648112

Claim:
A method of treating cancer in a subject, said method comprising: administering to said subject an effective amount of a compound selected from the group consisting of urolithin B, urolithin A, methyl-urolithin A, hydroxyl-urolithin A, and a compound represented by the structure: wherein R 1 is selected from the group consisting of H, OH, and OR 3 ; R 2 is H or C 1 -C 6 alkyl; and R 3 is C 1 -C 6 alkyl; wherein said cancer is selected from the group consisting of a sarcoma, a melanoma, a squamous cell carcinoma of the mouth, throat, larynx, or lung, a genitourinary cancer selected from cervical or bladder cancer, a hematopoietic cancer, a head and neck cancer, a nervous system cancer, prostate cancer, pancreatic cancer, and colon cancer.